TREAT-AD: TaRget Enablement to Accelerate Therapy Development for AD

There is a newer version of the record available.

Published September 20, 2023 | Version v2
Report Open

IUSM-Purdue TREAT-AD Center Target Enabling Component Establishing a Flow Scheme to Discover Novel PLCγ2 Chemical Probes

Description

A Target Enabling Component describing the screening efforts for PLCG2

Files

PLCG2 Screening TEP V1.pdf

Files (762.7 kB)

Name Size
md5:d130ae271ec4c32ecf1da2b7a9f40d6d
762.7 kB Preview Download